Brad T.

Senior Medical Director, Medical Affairs at SpringWorks Therapeutics

Brad T. has extensive experience in the medical and pharmaceutical industry. Brad currently works at SpringWorks Therapeutics as a Senior Medical Director, leading the Medical Affairs team. Prior to that, they served as the Sr. Director and US Medical Science Liaison Lead at the same company. Brad also worked as an Independent Consultant in the field of Medical Affairs.

In their previous roles, Brad worked as a Director of Medical Science Liaisons at Ultragenyx Pharmaceutical Inc., where they managed a team of professionals. Before that, they were a Senior Medical Science Liaison at Alexion Pharmaceuticals, Inc., specializing in Metabolic Diseases. Brad collaborated with key opinion leaders (KOLs), conducted medical affairs initiatives, and provided scientific expertise to the medical community.

Brad's career also includes several positions at Amgen, where they held various roles in scientific affairs and medical liaison related to different therapeutic areas, including Inflammation, Oncology, and Bone Health. Brad started their career as a pharmacist, working at CVS Pharmacy and Rite Aid Pharmacy. Brad also served as a Post-Doctoral Fellow at Daiichi Sankyo, where they developed and maintained a medical information database.

Overall, Brad T. has a strong background in medical affairs, scientific expertise, and extensive experience in building relationships with key stakeholders in the medical and pharmaceutical industry.

Brad T. attended Rutgers, Ernest Mario School of Pharmacy from 1997 to 2003. Brad obtained a PharmD degree, a Bachelor of Science degree, a Doctor of Pharmacy degree, and a Bachelor of Pharmacy (BPharm) degree, all in the field of Pharmacy.

Links

Previous companies

Daiichi Sankyo logo
Alexion Pharmaceuticals logo
Ultragenyx Pharmaceutical logo
Rite Aid logo
Amgen logo

Timeline

  • Senior Medical Director, Medical Affairs

    January, 2022 - present

  • Sr. Director, US Medical Science Liaison Lead

    April, 2019

View in org chart